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Valorization Addendum 
According to the American Society of Plastic Surgeons (ASPS), 1,790,832 aesthetic surgical 
procedures were performed in the US during 2017. Of these, there were 129,753 
abdominoplasties, 246,354 liposuctions, and 9,075 body uplifts, Altogether 385,182 body 
contouring surgeries in one year. Of note, abdominoplasties more than doubled in number since 
2000, when 62,713 abdominoplasties were performed.1 
 
When assigning a value to a surgical procedure such as an abdominoplasty, it would be easy to 
monetize it by calculating its financial value and its contribution to the economy. Nevertheless, 
this would omit the considerable positive effect of such an aesthetic-reconstructive procedure 
on those who underwent it, despite the risks and costs. The removal of a hanging panniculus for 
example, improves a person’s self-esteem, level of activity and day to day comfort because the 
discomfort, intertrigo, and backaches -helped by a tighter core are eased. Moreover, in a market-
based economy it is reasonable to assume that a person who is content and has a better self-
esteem would contribute by producing and consuming more. This thesis chronicled the advances 
made in body contouring surgery since Grazer 1973 and Grazer and Goldwyn 1977 first pointed 
out the safety issues in abdominoplasty and since Illouz introduced liposuction to the US in 
1981.2-4 Since then, the general advances in anesthesia, techniques and medical care have 
rendered body contouring surgery safer and its outcomes more predictable. The thesis relates 
the author’s approach to this field and the effort to further improve the safety and effectiveness 
of body contouring into the future.  
 
Obesity has reached an epidemic proportion in the western world and during a visit to 
Amsterdam in 2012 at the NVEPC 6th International Congress on Body Contouring, a Netherlands 
plastic surgeon surprised me by conveying that morbid obesity was no longer an “American 
problem”, it has also become a problem in the Netherlands. What’s more, the patient I was 
assigned to, turned out to be a massive weight loss patient who successfully lost weight with her 
Lap-Band port still in place.  Obesity is a public health problem. The Center for Disease Control 
and Prevention (CDC) website discloses that 39% of Americans in 2015-2016 were obese, that 
the estimated annual medical cost of obesity in the United States was $147 billion (in 2008), and 
the medical cost for people who are obese was $1,429 higher than for normal weight adults. 
Morbid obesity is about 8% and the CDC considers obesity an epidemic.5 
Bariatric surgery has been recognized by the National Institute of Health (NIH) to be the only 
effective treatment for severe obesity. Bariatric surgeries are effective in that the majority of 
individuals are successful in maintaining 50% or more of their excess weight loss following 
bariatric surgery.6 However, despite the improvement in their health, sagging tissues plague 
those who undergo bariatric surgery and their body image issues and discomfort lead them to 
seek body uplift type surgeries. According to the ASPS there was a 4000% increase in body uplifts 
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since 2000.1 A staged approach to these surgeries as a means to limit complications and 
untoward sequelae has been described in this thesis through classifying this surgery massive 
weight loss surgery.7 Staging the procedures kept complications at bay and helped the 
understanding of the massive weight loss problem. The study of massive weight loss surgery also 
raised the question if pre-existing morbid obesity in it of itself, places candidates for surgery in a 
medically higher risk category regardless of the type of surgery planned.  
According to data published on the CDC website (page last reviewed on February 5, 2018), deep 
vein thrombosis and pulmonary embolism (DVT/PE) is estimated to affect approximately 900,000 
people in the (US, 0. 1% - 0. 2% of the population) each year, although the precise number is 
unknown.8,9 Estimates further suggest that 60,000-100,000 Americans die premature death due 
to DVT/PE each year and that 10 to 30% of those diagnosed, will die within one month of 
diagnosis with sudden death. Sudden death is the first symptom in about 25% of people who 
have a PE. It is also estimated that 50% of those who have had DVT will have long-term 
complications as in post-phlebitic leg syndrome, that 33% will have another DVT within 10 years, 
and that approximately 5 to 8% of the U.S. population has a genetic risk factor for DVT originating 
from disorders known as inherited thrombophilias.8,9  
 
The health care costs of DVT/PE are estimated at $10 billion or more each year in the United 
States. Over half of blood clots are related to a recent hospitalization or surgery and most of 
these do not occur until after discharge.10-13 Furthermore, despite estimates that as many as 70% 
of cases of hospital derived DVT/PE could be prevented, less than 50% of these patients receive 
adequate prevention measures.14-16  
The statistics, even if half true are sobering.  The CDC therefore recommends that best-practices, 
proven prevention tools and evidence-based education tools be “shared for partners and 
stakeholders”.  Accordingly, it is wished that this thesis will contribute in some measure to this 
effort. 
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